Alcon Launches TRYPTYR in U.S. for Dry Eye Disease Treatment
TRYPTYR (acoltremon ophthalmic solution 0.003%) stimulates tear production via TRPM8 activation and is now available in the U.S. An intriguing…
LENZ Therapeutics and Théa Partner to Bring First Aceclidine-Based Eye Drop for Presbyopia to Canada
Canada preps for a presbyopia upgrade as LENZ100 edges closer to potential FDA approval. LENZ Therapeutics (San Diego, USA) and…
latest posts
